References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Hombrouck (2008) | Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137. | AAC | IN HIV1 Lab: 3 |
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Hombrouck (2008) | Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137. | AAC | IN HIV1 Lab: 3 |